Title: Interventions for Treating Depression After Stroke
Abstract: HomeStrokeVol. 40, No. 7Interventions for Treating Depression After Stroke Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBInterventions for Treating Depression After Stroke Maree L. Hackett, PhD, Craig S. Anderson, PhD, FRACP, FAFPHM, Allan O. House, DM, MRCP, MRCPsych and Jun Xia, BA Maree L. HackettMaree L. Hackett From the George Institute for International Health (M.L.H., C.S.A.), University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia; the Leeds Institute of Health Sciences (A.O.H.), University of Leeds, UK; and the Cochrane Schizophrenia Group (J.X.), POPE building, Nottingham University, UK. , Craig S. AndersonCraig S. Anderson From the George Institute for International Health (M.L.H., C.S.A.), University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia; the Leeds Institute of Health Sciences (A.O.H.), University of Leeds, UK; and the Cochrane Schizophrenia Group (J.X.), POPE building, Nottingham University, UK. , Allan O. HouseAllan O. House From the George Institute for International Health (M.L.H., C.S.A.), University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia; the Leeds Institute of Health Sciences (A.O.H.), University of Leeds, UK; and the Cochrane Schizophrenia Group (J.X.), POPE building, Nottingham University, UK. and Jun XiaJun Xia From the George Institute for International Health (M.L.H., C.S.A.), University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia; the Leeds Institute of Health Sciences (A.O.H.), University of Leeds, UK; and the Cochrane Schizophrenia Group (J.X.), POPE building, Nottingham University, UK. Originally published14 May 2009https://doi.org/10.1161/STROKEAHA.109.547059Stroke. 2009;40:e487–e488Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: May 14, 2009: Previous Version 1 Depression is an important consequence of stroke, affecting one third of patients, that often goes undetected or is inadequately treated and managed. This is an update of a Cochrane review we first published in 2004 to determine whether pharmacological, psychological, or electroconvulsive treatment (ECT) of depression in patients with stroke can improve outcome.1Search StrategyWe searched the trials registers of the Cochrane Stroke Group (last searched October 2007) and the Cochrane Depression Anxiety and Neurosis Group (last searched February 2008). In addition, we searched the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 1, 2008), MEDLINE (1966 to May 2006), EMBASE (1980 to May 2006), CINAHL (1982 to May 2006), PsycINFO (1967 to May 2006), and other databases. We also searched reference lists, clinical trials registers, conference proceedings, and dissertation abstracts and contacted authors, researchers, and pharmaceutical companies.Selection CriteriaWe considered all truly randomized controlled trials comparing pharmaceutical agents with placebo, or various forms of psychotherapy or ECT with standard care (or attention control), to treat depression in patients with stroke.ResultsWe identified 16 trials (17 interventions), with 1655 participants at entry. Data were available for 13 pharmaceutical trials and 4 trials of psychotherapy. There were no trials of ECT. There was evidence of benefit of pharmacotherapy in terms of a complete remission of depression (odds ratio [OR] 0.47, 95% confidence interval [CI] 0.22 to 0.98) and a reduction (improvement) in scores on depression rating scales, but there was also evidence of an increase in adverse events (OR 1.96; 95% CI 1.19 to 3.24). There was no evidence of benefit of psychotherapy. The analyses were complicated by the lack of standardized diagnostic and outcome criteria including multiple measures of depression within and between trials without a priori identification of the primary measure, differing analytic methods, with few trials prospectively recording and reporting adverse events.DiscussionThe addition of 5 new pharmacotherapy trials since 2004 has altered previous findings to show a small but significant effect of pharmacotherapy for treating depression and reducing depressive symptoms after stroke and an associated significant increase in adverse events. Antidepressants should be used with caution in people with persistent depressive symptoms after stroke as little is known about the risks, especially of seizures, falls, and delirium. More research is required before recommendations can be made about the routine use of such treatments in light of the increase in adverse events and a lack of efficacy of selective serotonin reuptake inhibitors except in those with severe depression in nonstroke populations.2 With the addition of 2 new psychotherapy trials there is still no evidence to support the use of psychotherapy on its own to treat depression after stroke.There is a need for further research using more rigorous methods including concealment of randomization, and blinded treatment allocation and outcome assessments. Future trials to treat depression after stroke should be of adequate power, clearly identify a priori primary and secondary end points, and include prospective assessment and complete reporting of adverse events. Any treatment strategy should be continued for a sufficient duration and follow-up, so that rates of relapse or maintenance of remission can be assessed.We thank the Cochrane Stroke Group, particularly Brenda Thomas, for searching the Cochrane Stroke Register and assistance with developing the search strategies. We also thank Hazel Fraser for assistance throughout the review process.Sources of FundingThe 2004 published review was supported by a grant from the Stroke Society of Australasia, with additional financial assistance provided by the Academic Unit of Psychiatry, the University of Leeds, and the Department of Clinical Neurosciences, the University of Edinburgh.DisclosuresDuring the completion of this work Maree Hackett was in receipt of a National Health and Medical Research Council Public Health (Australia) Fellowship (2006–2009).FootnotesCorrespondence to Maree Hackett, The George Institute for International Health, PO Box M201, Missenden Road, Sydney, NSW 2050, Australia. E-mail [email protected] References 1 Hackett ML, Anderson CS, House AO, Xia J. Interventions for treating depression after stroke. Cochrane Database of Systematic Reviews. 2008: Issue 2. Art. No.: CD003437. DOI: 003410.001002/14651858.CD14003437.pub14651853.MedlineGoogle Scholar2 Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration. PLoS Medicine. 2008; 5: 260–268.Google Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Wrapson W, Dorrestein M, Wrapson J, Theadom A, Kayes N, Snell D, Rutherford S, Roche M, Babbage D, Taylor S and Siegert R (2021) A Feasibility Study of a One-to-One Mindfulness-Based Intervention for Improving Mood in Stroke Survivors, Mindfulness, 10.1007/s12671-020-01583-4, 12:5, (1148-1158), Online publication date: 1-May-2021. Kneebone I (2016) A Framework to Support Cognitive Behavior Therapy for Emotional Disorder After Stroke, Cognitive and Behavioral Practice, 10.1016/j.cbpra.2015.02.001, 23:1, (99-109), Online publication date: 1-Feb-2016. Desmaele S, Putman K, De Wit L, Dejaeger E, Gantenbein A, Schupp W, Steurbaut S, Dupont A and De Paepe K (2016) A comparative study of medication use after stroke in four countries, Clinical Neurology and Neurosurgery, 10.1016/j.clineuro.2016.07.007, 148, (96-104), Online publication date: 1-Sep-2016. Ellis-Hill C, Gracey F, Thomas S, Lamont-Robinson C, Thomas P, Marques E, Grant M, Nunn S, Cant R, Galvin K, Reynolds F and Jenkinson D (2015) 'HeART of Stroke (HoS)', a community-based Arts for Health group intervention to support self-confidence and psychological well-being following a stroke: protocol for a randomised controlled feasibility study, BMJ Open, 10.1136/bmjopen-2015-008888, 5:8, (e008888), Online publication date: 1-Aug-2015. Juang H, Chen P and Chien K (2015) Using antidepressants and the risk of stroke recurrence: report from a national representative cohort study, BMC Neurology, 10.1186/s12883-015-0345-x, 15:1, Online publication date: 1-Dec-2015. Ayerbe L, Ayis S, Crichton S, Wolfe C and Rudd A (2013) The long-term outcomes of depression up to 10 years after stroke; the South London Stroke Register, Journal of Neurology, Neurosurgery & Psychiatry, 10.1136/jnnp-2013-306448, 85:5, (514-521), Online publication date: 1-May-2014. Pedroso V, Souza L and Teixeira A (2014) Síndromes neuropsiquiátricas associadas a acidentes vasculares encefálicos: revisão de literatura, Jornal Brasileiro de Psiquiatria, 10.1590/0047-2085000000021, 63:2, (165-176), Online publication date: 1-Jul-2014. Anderson S and Whitfield K (2012) Social identity and stroke: 'they don't make me feel like, there's something wrong with me', Scandinavian Journal of Caring Sciences, 10.1111/j.1471-6712.2012.01086.x, 27:4, (820-830), Online publication date: 1-Dec-2013. Koh K (2013) Poststroke Depression: Mechanisms and Management Somatization and Psychosomatic Symptoms, 10.1007/978-1-4614-7119-6_16, (207-223), . I. Kneebone I and B. Lincoln N (2012) Psychological Problems after Stroke and Their Management: State of Knowledge, Neuroscience and Medicine, 10.4236/nm.2012.31013, 03:01, (83-89), . Kootker J, Fasotti L, Rasquin S, van Heugten C and Geurts A (2012) The effectiveness of an augmented cognitive behavioural intervention for post-stroke depression with or without anxiety (PSDA): the Restore4Stroke-PSDA trial, BMC Neurology, 10.1186/1471-2377-12-51, 12:1, Online publication date: 1-Dec-2012. van het Hoofd M, Roelse H, Kwakkel G, Schepers V and van de Port I (2013) Does exercise therapy affect depression or depressive symptoms after stroke?, Physical Therapy Reviews, 10.1179/1743288X11Y.0000000016, 16:3, (191-200), Online publication date: 1-Jun-2011. (2011) References Psychological Management of Stroke, 10.1002/9781119961307.refs, (493-588), Online publication date: 25-Nov-2011. Kapfhammer H (2011) Psychische Störungen bei somatischen Krankheiten Psychiatrie, Psychosomatik, Psychotherapie, 10.1007/978-3-642-03637-8_76, (2511-2598), . July 2009Vol 40, Issue 7 Advertisement Article InformationMetrics https://doi.org/10.1161/STROKEAHA.109.547059 Manuscript receivedJanuary 6, 2009Manuscript acceptedJanuary 12, 2009Originally publishedMay 14, 2009 Keywordsstroke recoverytreatmentmeta-analysisdepressionPDF download Advertisement